Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-27
DOI
10.3389/fphar.2018.01380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche
- (2017) Allison L. Boyd et al. NATURE CELL BIOLOGY
- Current Understanding in Neutrophil Differentiation and Heterogeneity
- (2017) Chang-Won Hong Immune Network
- All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study
- (2016) Richard F. Schlenk et al. ANNALS OF HEMATOLOGY
- All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo
- (2016) H. S. Ma et al. BLOOD
- Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy
- (2016) Y. L. Liu et al. BLOOD
- PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy
- (2016) L Cicconi et al. LEUKEMIA
- PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity
- (2016) Nélida Inés Noguera et al. Oncotarget
- Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid
- (2015) H. J. M. P. Verhagen et al. BLOOD
- International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
- (2015) H. Dombret et al. BLOOD
- Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
- (2015) Stéphane Prost et al. NATURE
- Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: Achievements and challenges
- (2014) Michael Lübbert et al. CANCER
- Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia
- (2014) S. Thomas et al. HAEMATOLOGICA
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- All-trans retinoic acid combined with 5-Aza-2′-deoxycitidine induces C/EBPα expression and growth inhibition in MLL-AF9-positive leukemic cells
- (2012) Atsushi Fujiki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling
- (2012) Katrin Faber et al. JOURNAL OF CLINICAL INVESTIGATION
- GSK3 is a regulator of RAR-mediated differentiation
- (2012) K Gupta et al. LEUKEMIA
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA
- (2009) A. K. Burnett et al. BLOOD
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- Identification of 6-Benzylthioinosine as a Myeloid Leukemia Differentiation-Inducing Compound
- (2008) D. N. Wald et al. CANCER RESEARCH
- Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B
- (2008) R. F. Schlenk et al. HAEMATOLOGICA
- Azacytidine causes complex DNA methylation responses in myeloid leukemia
- (2008) C. Stresemann et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started